Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Miyoung Yeom"'
Autor:
Doyoung Kim, Jeongjin Kim, Gyochang Keum, Hak Joong Kim, Rina Kwag, Haeun Lee, Jieon Lee, Yakdol Cho, Byungsun Jeon, Miyoung Yeom, Hyunah Choo, Jiwan Woo
Publikováno v:
Journal of Medicinal Chemistry. 64:13766-13779
5-HT7R belongs to a family of G protein-coupled receptors and is associated with a variety of physiological processes in the central nervous system via the activation of the neurotransmitter serotonin (5-HT). To develop selective and biased 5-HT7R li
Autor:
Rina, Kwag, Jieon, Lee, Doyoung, Kim, Haeun, Lee, Miyoung, Yeom, Jiwan, Woo, Yakdol, Cho, Hak Joong, Kim, Jeongjin, Kim, Gyochang, Keum, Byungsun, Jeon, Hyunah, Choo
Publikováno v:
Journal of medicinal chemistry. 64(18)
5-HT
Autor:
Soyeon Lee, Kyung Il Choi, Youngjae Kim, Sun-Joon Min, Hak Joong Kim, Miyoung Yeom, Hyewhon Rhim, Hyunah Choo, Jihye Seong, Jinsung Tae
Publikováno v:
Bulletin of the Korean Chemical Society. 39:1083-1089
Publikováno v:
European Journal of Medicinal Chemistry. 110:302-310
To discover a novel 5-HT7R antagonist for treatment of depression, we designed N-acyl-carbazole derivatives which were synthesized and biologically evaluated against 5-HT7R. Among total 30 compounds synthesized, four compounds 27-30 showed good bindi
Autor:
Hyewhon Rhim, Bongjin Moon, Youhoon Chong, Bryan L. Roth, Jeeyeon Kim, Ghilsoo Nam, Xi Ping Huang, Jinsung Tae, Hyunah Choo, Kang Ho Lee, Il Han Choo, Gyochang Keum, Youngjae Kim, Miyoung Yeom
Publikováno v:
ChemMedChem. 8(11)
The 5-HT7 receptor (5-HT7 R) is a promising therapeutic target for the treatment of depression and neuropathic pain. The 5-HT7 R antagonist SB-269970 exhibited antidepressant-like activity, whereas systemic administration of the 5-HT7 R agonist AS-19
Autor:
Bongjin Moon, Taekeun Kim, Jiyoon Kim, Jaeick Lee, Eun Jeong Lim, Ki Duk Park, Hyunah Choo, Gyochang Keum, Miyoung Yeom, Sun-Joon Min, Seonmi Jo, Il Han Choo, C. Justin Lee, Hyeri Park, Ghilsoo Nam
Publikováno v:
Bioorganicmedicinal chemistry. 21(17)
In Parkinson's disease, the motor impairments are mainly caused by the death of dopaminergic neurons. Among the enzymes which are involved in the biosynthesis and catabolism of dopamine, monoamine oxidase B (MAO-B) has been a therapeutic target of Pa